In-vitro diagnostics market to grow at a CAGR of 5.1% (2024 – 2030): Wissen Research
The global in vitro diagnostics market is estimated at USD 82.5 billion in 2023 and is projected to reach USD 117.1 billion by 2030, expected to grow at a CAGR of 5.1% during the forecast period, 2024-2030
/EIN News/ -- Sheridan, March 26, 2025 (GLOBE NEWSWIRE) -- According to the latest market report published by Wissen Research, the global in-vitro diagnostics market is projected to be valued at 82.5 billion in 2023. Furthermore, the market is expected to grow at a CAGR of 5.1% during the forecast period from 2024 to 2030.
IVD Report Pricing @ https://www.wissenresearch.com/Pricing/
In-vitro Diagnostics Market Summary
| Particulars | Details |
| Report | In Vitro Diagnostics Market |
| Forecast Period | 2024-2030 |
| Base Year | 2023 |
| Format | |
| Estimated Market Size (2024) | USD 86,944 Million |
| CAGR (2024-2030) | 5.1% |
| Number of Pages | 150+ |
| Number of Tables | 170+ |
| Number of Figures | 30+ |
| Key Segments |
In Vitro Diagnostics Market Product Outlook (Kits, Reagents, and Consumables, Instruments, Software & Services) In Vitro Diagnostics Market Test Outlook (Laboratory Testing and Point of Care Testing) In Vitro Diagnostics Market Technology Outlook (Clinical Chemistry, Immunoassay, Molecular Diagnostics, Hematology, Microbiology, Coagulation, Urinalysis, Others) Note: Others include mass spectrometry, among others In Vitro Diagnostics Market Therapeutic Area Outlook (Infectious Disease, Cardiology, Endocrinology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Genetic Testing, Allergy, Bone & Mineral Testing, Others) Note: Others include blood screening, among others In Vitro Diagnostics Market End-User Outlook (Clinics & Hospitals, Clinical Laboratories, Home Care Settings, Blood Banks, Pharmaceutical & Biotechnology Companies, Academic Institutions, Others) |
| Regions Covered |
|
| Key Players Covered | F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Becton, Dickinson and Company (US), Danaher Corporation (Germany), Siemens Healthineers (Germany), Thermo Fisher Scientific Inc. (US), Sysmex Corporation (Japan), QuidelOrtho Corporation (US), Werfen S.A. (Spain), Hologic, Inc. (US), Exact Sciences (US), Qiagen N.V. (The Netherlands), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), and bioMérieux SA (France) |
US In-vitro Diagnostics Market Size
Further, the US with USD 41.8 billion market in 2023, holds majority share in the global In-vitro Diagnostics market and is likely to remain the leading region growing a CAGR of 5.0% within this market, during the forecast period.
Growth Drivers
- Rising incidence of chronic and infectious disease
- Rising demand for point of care testing
- Increasing disposable income
- Increasing aging population
Opportunities
- Expanding market in emerging economies
- Government initiatives and funding for innovation in-vitro diagnostic industry
Immunoassay Accounted for The Largest Share of In-Vitro Diagnostics Market by Technology Type
Within in vitro diagnostics market, immunoassay based testing holds the highest share in 2024 followed by clinical chemistry and molecular diagnostics. It is worth mentioning that IVD developers are investing heavily on their R&D to develop advanced immunological instruments and testing services.
This was driven by a complex interplay of factors, with industry leaders like Abbott (through its ID NOW™ platform), Roche (Cobas® systems), and Cepheid (GeneXpert®) dominating the landscape through their innovative immunoassay and molecular diagnostic platforms. The segment's growth was significantly propelled by the widespread adoption of multiplex PCR systems, next-generation sequencing platforms, and rapid immunoassays, particularly during the COVID-19 pandemic when companies like bioMérieux (BioFire® FilmArray®) scaled their operations to meet unprecedented demand. The market was further boosted by product launches such as BD's MAX™ platform for respiratory infections, alongside significant investments in In-vitro diagnostics solutions that enhanced the accessibility of such tests in the comfort of patient’s home.
North America Held the Largest Market Share (>51%) in In-vitro Diagnostics Market in 2023
In-vitro diagnostics testing market analysis encompassed a detailed evaluation of five key regions:
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- Latin America.
These regions were assessed based on healthcare infrastructure, regulatory frameworks, technological advancements, and market trends. North America retained the largest market share, with US In-vitro diagnostics market holding 50.6% market share in 2023, owing to its advanced healthcare infrastructure, early adoption of innovative imaging technologies, and the strong presence of leading market players like Abbott Laboratories, Siemens Healthineers, and Thermo-Fischer Scientific.
BRAND ANALYSIS: IN-VITRO DIAGNOSTICS MARKET
| Company |
Diagnostics Revenue (USD Billion, 2023) |
Product Sales (2023, USD Billion) |
Upcoming Key Product / Growth Contributors | Year | Key Product’s Global Installation |
| Roche | 15.7 | 1.11 | Nanospore Sequencer | 2025+ | >5,200 – Cobas Pure / Pro Integrated Solution (As of December 2023) |
| Abbott | 10.0 | 4.62 | Traumatic Brain Injury (TBI) Test | NA | XX |
| Danaher | 9.6 | XX | XX | XX |
| Becton and Dickinson | 5.1 | XX | XX | XX |
| Siemens Healthineers | 4.9 | XX | XX | XX |
Request Customized Report @ https://www.wissenresearch.com/ask-for-customization/
Contact us for free sample In-vitro diagnostics market report: https://www.wissenresearch.com/contact/
Other Latest Reports from Wissen Research
- Dental Implants & Prosthetics Market
- Diagnostic Imaging Diagnostics Market
- Remote Patient Monitoring Market
- Radioactive Tracers Market
- Point of Care Testing Market
About us
Wissen Research is a leading market research firm that serves over 800 clients, with 40% of the top 2,000 companies relying on us for insights into key business questions and the identification of new high-growth and niche revenue opportunities. We offer exclusive market intelligence from over 120 subject matter experts and analysts, complemented by our high-growth niche market studies and consulting services.
Our research methodology delivers quantifiable and actionable insights into interconnected market ecosystems shaped by disruptive technologies and emerging markets. We not only focus on factors that will impact our clients' revenue but also explore what could affect their customers' revenue by revealing latent and adjacent market opportunities.
We collaborate across all B2B sectors, engaging with C-level executives in areas such as R&D, intellectual property, strategy, marketing, sales, product development, and M&A.
Mayur Jain
Wissen Research LLC
Gould St, Ste R
Sheridan, WY 82801
Phone: (+91) 7814300364
info@wissenresearch.com
Distribution channels:
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release